Skip to content
Axcess News – Lifestyle
Author:
Ensysce Biosciences
Ensysce Biosciences Announces First Peer-Reviewed Clinical Publication Demonstrating Oral Overdose Protection with MPAR(R) Technology
March 6, 2026
Ensysce Biosciences Initiates Review of Strategic Alternatives to Enhance Shareholder Value
March 5, 2026
Ensysce Biosciences Invited to Participate in Upcoming Scientific and Industry Events
March 5, 2026
←
Previous Page
1
2